Found: 30
Select item for more details and to access through your institution.
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8929, doi. 10.3390/ijms25168929
- By:
- Publication type:
- Article
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.
- Published in:
- Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-02115-y
- By:
- Publication type:
- Article
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 15, p. 1294, doi. 10.3390/cells13151294
- By:
- Publication type:
- Article
Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges.
- Published in:
- Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2024.1416946
- By:
- Publication type:
- Article
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5083, doi. 10.3390/ijms25105083
- By:
- Publication type:
- Article
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45902-y
- By:
- Publication type:
- Article
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57<sup>Kip2</sup> targeting.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44130-0
- By:
- Publication type:
- Article
Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal Muscles.
- Published in:
- Muscles (2813-0413), 2023, v. 2, n. 2, p. 187, doi. 10.3390/muscles2020014
- By:
- Publication type:
- Article
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2823, doi. 10.3390/cancers15102823
- By:
- Publication type:
- Article
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3226, doi. 10.3390/ijms24043226
- By:
- Publication type:
- Article
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2673, doi. 10.3390/ijms24032673
- By:
- Publication type:
- Article
The botanical drug PBI-05204, a supercritical CO<sub>2</sub> extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1071176
- By:
- Publication type:
- Article
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13281, doi. 10.3390/ijms232113281
- By:
- Publication type:
- Article
Radioresistance in rhabdomyosarcomas: Much more than a question of dose.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1016894
- By:
- Publication type:
- Article
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8336, doi. 10.3390/ijms23158336
- By:
- Publication type:
- Article
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.835642
- By:
- Publication type:
- Article
Epigenetic remodelling in human hepatocellular carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02297-2
- By:
- Publication type:
- Article
New Insights on the Nuclear Functions and Targeting of FAK in Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 4, p. 1998, doi. 10.3390/ijms23041998
- By:
- Publication type:
- Article
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02154-8
- By:
- Publication type:
- Article
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 2956, doi. 10.3390/cells10112956
- By:
- Publication type:
- Article
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10671, doi. 10.3390/ijms221910671
- By:
- Publication type:
- Article
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 5, p. 1, doi. 10.1038/s41419-021-03737-1
- By:
- Publication type:
- Article
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20386-8
- By:
- Publication type:
- Article
FAK Signaling in Rhabdomyosarcoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8422, doi. 10.3390/ijms21228422
- By:
- Publication type:
- Article
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.01230
- By:
- Publication type:
- Article
Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery.
- Published in:
- Nature Biotechnology, 2020, v. 38, n. 1, p. 50, doi. 10.1038/s41587-019-0296-7
- By:
- Publication type:
- Article
Chemical genomics reveals histone deacetylases are required for core regulatory transcription.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11046-7
- By:
- Publication type:
- Article
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, p. 1, doi. 10.1186/s13045-015-0206-5
- By:
- Publication type:
- Article
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.
- Published in:
- Clinical Epigenetics, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13148-015-0107-z
- By:
- Publication type:
- Article